ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00265759
Brief Title: Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer

First Submitted : December 14, 2005
First Submitted that Met QC Criteria : December 14, 2005
First Posted : December 15, 2005 (Estimate)

Results First Submitted : February 14, 2017
Results First Submitted that Met QC Criteria : February 14, 2017
Results First Posted : March 30, 2017

Last Update Submitted that Met QC Criteria : April 6, 2018
Last Update Posted : May 8, 2018